Kosuyolu Heart Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1993
NCT01451320
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Kosuyolu Kartal Heart Training and Research Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

tirofiban (aggrastat) (1 trial)

Drugs in Other Trials (4)

alteplase (Activase) (1 trial)

enoxaparin (lovenox) (1 trial)

streptokinase (streptase) (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5